Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TYO/4892 stock hub

TYO/4892 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TYO/4892is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
6.7B
Tokyo Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TYO/4892
In the news

Latest news · TYO/4892

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.7P50 15.8P75 21.7
Trailing P/En/a
P25 11.7P50 15.2P75 22.3
ROE-28.8
P25 -1.6P50 7.1P75 11.9
ROIC-236.9
P25 -0.6P50 6.2P75 14.3
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TYO/4892 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
174
Groups with data
11
Currency
JPY
Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Japan
Country code
JP
Employees
23
Employees Change
2%
Employees Change Percent
9.52
Enterprise value
JPY 4.3B
Exchange
Tokyo Stock Exchange
Financial currency
JPY
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
JP3311800001
Last refreshed
2026-05-10
Market cap
JPY 6.7B
Price
JPY 677
Price currency
JPY
Rev Per Employee
10,000,000x
Sector
Healthcare
Sic
3841
Symbol
tyo/4892
Website
https://www.cyfusebio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-11.31%
EV Earnings
-5.68x
EV/FCF
-7.45x
EV/Sales
18.83x
FCF yield
-8.61%
P/B ratio
2.45x
P/S ratio
29.33x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

17
MetricValue
Gross margin
49.13%
Gross Profit
JPY 113M
Gross Profit Growth
606.25%
Gross Profit Growth Q
780%
Gross Profit Growth3 Y
-22.31%
Net Income
JPY -763M
Net Income Growth Quarters
1%
Net Income Growth Years
1%
Pretax Margin
-330.87%
Profit Per Employee
JPY -33.2M
ROA
-13.31
Roa5y
-8.55
ROCE
-24.38
ROE
-28.8
Roe5y
-16.9
ROIC
-236.9
Roic5y
-177.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

9
MetricValue
Cagr1y
-30.44%
Cagr3y
-20.59%
EPS Growth Quarters
2
EPS Growth Years
1
Revenue Growth
325.93x
Revenue Growth Q
503.57x
Revenue Growth Quarters
2x
Revenue Growth Years
1x
Revenue Growth3 Y
-14.96x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
JPY 0.06
Assets
JPY 4.3B
Cash
JPY 3.7B
Current Assets
JPY 3.9B
Current Liabilities
JPY 866M
Debt
JPY 1.3B
Debt Equity
JPY 0.48
Debt FCF
JPY -2.26
Equity
JPY 2.8B
Interest Coverage
-55.27
Liabilities
JPY 1.5B
Long Term Assets
JPY 332M
Long Term Liabilities
JPY 644M
Net Cash
JPY 2.4B
Net Cash By Market Cap
JPY 35.8
Net Cash Growth
9.77%
Net Debt Equity
JPY -0.88
Tangible Book Value
JPY 2.8B
Tangible Book Value Per Share
JPY 286
WACC
10.45

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
4.54
Inventory Turnover
1.64
Net Working Capital
JPY 11M
Quick ratio
4.35
Working Capital
JPY 3.1B
Working Capital Turnover
JPY 0.08

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-9.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
1Y total return
-30.42%
200-day SMA
625.1
3Y total return
-49.93%
50-day SMA
640.4
50-day SMA vs 200-day SMA
50over200
All Time High
2,468
All Time High Change
-72.57%
All Time High Date
2022-12-05
All Time Low
430
All Time Low Change
57.44%
All Time Low Date
2024-11-20
ATR
27.37
Beta
1.46
Beta1y
-0.05
Beta2y
0.97
Ch YTD
14.75
High
684
High52
1,068
High52 Date
2025-05-16
High52ch
-36.61%
Low
667
Low52
516
Low52 Date
2025-12-15
Low52ch
31.2%
Ma50ch
5.71%
Price vs 200-day SMA
8.31%
RSI
53.1
RSI Monthly
46.22
RSI Weekly
55.11
Sharpe ratio
-0.69x
Sortino ratio
-0.87
Total Return
-9.33%
Tr YTD
14.75
Tr1m
11.35%
Tr1w
-0.15%
Tr3m
3.99%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
JPY -829M
Operating margin
-360.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
6,908,800%
Net Borrowing
439,000,000
Shares Insiders
11.64%
Shares Institutions
10.14%
Shares Out
9,963,900
Shares Qo Q
5.48%
Shares Yo Y
9.33%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

49
MetricValue
Adjusted FCF
JPY -581M
Average Volume
179,600x
Bv Per Share
286.6
CAPEX
JPY -47M
Ch1m
11.35
Ch1w
-0.15
Ch1y
-30.42
Ch3m
3.99
Ch3y
-49.93
Ch6m
16.72
Change
-0.59%
Change From Open
-0.59
Close
681
Days Gap
0
Depreciation Amortization
37,000,000
Dollar Volume
42,312,500
Earnings Date
2026-05-14
EBIT
JPY -829M
EBITDA
JPY -792M
EPS
JPY -86.69
F Score
3
FCF
JPY -581M
FCF EV Yield
-13.42x
FCF Per Share
JPY -58.31
Financing CF
1,256,000,000
Fiscal Year End
December
Founded
2,010
Income Tax
JPY 2M
Investing CF
-397,000,000
Is Primary Listing
1
Last Earnings Date
2026-02-13
Last Report Date
2025-12-31
Ma150
617.3
Ma150ch
9.67%
Ma20
667.2
Ma20ch
1.47%
Net CF
323,000,000
Next Earnings Date
2026-05-14
Open
681
Position In Range
58.82
Ppne
155,000,000
Price Date
2026-05-08
Ptbv Ratio
2.45
Relative Volume
0.35x
Revenue
230,000,000x
Tax By Revenue
0.87x
Tr6m
16.72%
Volume
62,500
Z Score
1.52
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TYO/4892 pay a dividend?

Capital-return profile for this ticker.

Performance

TYO/4892 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-30.4%
S&P 500 1Y: n/a
3Y total return
-49.9%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns TYO/4892?

Insider, institutional, and short-interest positioning.

Institutional ownership
+10.1%
Share of float held by funds and institutions
Insider ownership
+11.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+9.3%
Negative means the company is buying back shares.
Technical

TYO/4892 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
53.1
Neutral momentum band
Price vs 200-day MA
+8.3%
50/200-day relationship not available
Beta (5Y)
1.46
More volatile than the market
Sharpe ratio
-0.69
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TYO/4892

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tyo/4892 stock rating?

tyo/4892 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tyo/4892 analysis?

The full report lives at /stocks/tyo/4892/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tyo/4892?

The latest report frames tyo/4892 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tyo/4892 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

tyo/4892 stock profile: metrics, valuation and analysis | Agent AI Rynku Akcji